6 patents
Utility
Antibodies Targeting a Galactan-based O-antigen of K. Pneumoniae
13 Jul 23
Valeria SZIJARTO, Gábor NAGY, Luis GUACHALLA, Zehra VISRAM, Eszter NAGY, Jolanta Katarzyna LUKASIEWICZ
Filed: 16 Aug 22
Utility
Antibodies targeting a galactan-based O-antigen of K. pneumoniae
11 Oct 22
Valeria Szijarto, Gábor Nagy, Luis Guachalla, Zehra Visram, Eszter Nagy, Jolanta Katarzyna Lukasiewicz
Filed: 3 Nov 15
Utility
MDR E. Coli Specific Antibody
3 Jun 21
The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.
Eszter NAGY, Gábor NAGY, Valéria SZIJÁRTO, Zoltán MAGYARICS, Irina MIRKINA, Luis GUACHALLA, Adriana BADARAU, Gerhild ZAUNER, Jolanta LUKASIEWICZ
Filed: 4 Feb 21
Utility
MDR
9 Mar 21
The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.
Eszter Nagy, Gábor Nagy, Valéria Szijárto, Zoltán Magyarics, Irina Mirkina, Luis Guachalla, Adriana Badarau, Gerhild Zauner, Jolanta Lukasiewicz
Filed: 21 Dec 18
Utility
Klebsiella Pneumoniae O3 Specific Antibodies
28 Oct 20
A cross-neutralizing monoclonal antibody that specifically recognizes a cross-reactive epitope of the lipopolysaccharide (LPS) antigen structure of Klebsiella pneumoniae, which is an O3b epitope, cross-reacting with an O3a epitope and an O3 epitope, wherein the antibody is characterized by specific CDR sequences or VH and VL sequences.
Valeria SZIJÁRTO, Gábor NAGY, Luis GUACHALLA, Katharina RAMONI, Adriana BADARAU, Eszter NAGY, Tim ROLLENSKE, Hedda WARDEMANN, Irina MIRKINA
Filed: 5 Jul 20
Utility
CXCR4 Inhibitors and Uses Thereof
23 Oct 19
The present invention provides compounds, compositions thereof, and methods of using the same.
Elyse Marie Josee Bourque, Renato Skerlj
Filed: 20 Jun 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first